NewcelX Ltd. ( NCEL) - Key Metrics
NCEL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $0 | $1.29 | $0 | $0 |
| 2025Q2 | $0 | -$0.66 | -$0.62 | -$0.62 |
| 2024Q4 | $0 | $0.02 | -$0.81 | -$0.81 |
| 2024Q2 | $0 | -$0.49 | -$0.36 | -$0.36 |
| 2023Q4 | $0 | $0 | $0 | $0 |
NCEL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | 0% | 0.37 |
| 2025Q2 | 0% | -0.69 |
| 2024Q4 | 0% | -0.20 |
| 2024Q2 | 0% | -10.11 |
| 2023Q4 | 0% | -42 |
NCEL
Price: $2.83
52 week price:
Earnings Per Share: -2.16 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.3 million